Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion type Assertion NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_head.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion description "[To develop diagnostic tools with greater specificity for ovarian cancers, the present study was targeted at characterizing the biosynthetic capacity of the epithelial ovarian cancer cell lines from the American Type Culture Collection with respect to inhibin, activin, the related activin-binding protein follistatin (FS), and activin receptor type II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_provenance.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion evidence source_evidence_literature NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_provenance.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion SIO_000772 8593793 NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_provenance.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion wasDerivedFrom befree-2016 NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_provenance.
- NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_assertion wasGeneratedBy ECO_0000203 NP1347003.RArHLa_vdfhAytGbhdDHXtPmGCR3LrKuJuQYDDsE7B73g130_provenance.